Supported by expanding biotechnology investment and regenerative medicine research, the automated cell culture market was valued at USD 20.99 billion in the base year 2025 and is projected to reach USD 23.69 billion in 2026 and USD 63.15 billion by 2034, registering a CAGR of 13.02% during the forecast period 2026–2034. Competitive participants include Becton, Dickinson and Company,...